Recent Advances in Cancer Immunotherapy and Tumor Profiling Technologies

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

Cancer immunotherapy and cancer profiling are key areas of growth across the healthcare community. These vital areas will define the future of how cancer is screened, diagnosed, managed, and monitored. With technology areas such as exosome technology being implemented in profiling tumors, a paradigm shift can be brought about in how cancer is detected. Early detection of cancer will enable it to be controlled and managed in a better manner. New strides have been made in the development of immunological therapeutics, thereby increasing the treatment possibilities for patients suffering with certain types of hard to treat cancers.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Cancer profiling, exosome technology, extracellular vesicles, liquid biopsy, cancer therapeutics, immunotherapy

Table of Contents

Recent Advances in Cancer Immunotherapy and Tumor Profiling TechnologiesInnovations in Cancer Immunotherapy and Tumor Profiling Technologies Monoclonal Antibody Therapy for Urothelial CarcinomaLeveraging Exosome Biology for Tumor ProfilingExosome Biomarkers for Chronic Traumatic EncephalopathyEnhancing Exosome Isolation for Research ApplicationsClinical Trial Analysis and Industry InteractionsClinical Trial AnalysisIndustry Interactions




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.